The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Targeted Delivery of CRISPR/Cas9‐Mediated Cancer Gene Therapy via Liposome‐Templated Hydrogel Nanoparticles
Open accessAbstract
Due to its simplicity, versatility, and high efficiency, the clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 technology has emerged as one of the most promising approaches for treatment of a variety of genetic diseases, including human cancers. However, further translation of CRISPR/Cas9 for cancer gene therapy requires development of safe approaches for efficient, highly specific delivery of both Cas9 and single guide RNA to tumors. Here, novel core-shell nanostructure, liposome-templated hydrogel nanoparticles (LHNPs) that are optimized for efficient codelivery of Cas9 protein and nucleic acids is reported. It is demonstrated that, when coupled with the minicircle DNA technology, LHNPs deliver CRISPR/Cas9 with efficiency greater than commercial agent Lipofectamine 2000 in cell culture and can be engineered for targeted inhibition of genes in tumors, including tumors the brain. When CRISPR/Cas9 targeting a model therapeutic gene, polo-like kinase 1 (PLK1), is delivered, LHNPs effectively inhibit tumor growth and improve tumor-bearing mouse survival. The results suggest LHNPs as versatile CRISPR/Cas9-delivery tool that can be adapted for experimentally studying the biology of cancer as well as for clinically translating cancer gene therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“After loading with CRISPR/Cas9 targeting polo-like kinase 1 (plk1) gene, LHNPs effectively inhibited U87MG tumor growth [119].”
From Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities (2018) · cites this paper as [119]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Improved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016
CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
Gilbert, L. A., Larson, M. H., Morsut, L., Liu, Z., Brar, G. A., Torres, S. E., Stern-Ginossar, N., Brandman, O., Whitehead, E. H., Doudna, J. A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.044 · Cited by 3,696
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.021 · Cited by 3,299
Zuris, J. A., Thompson, D. B., Shu, Y., Guilinger, J. P., Bessen, J. L., Hu, J. H., Maeder, M. L., Joung, J. K., Chen, Z.-Y., & Liu, D. R. (2015) · Nature Biotechnology · doi:10.1038/nbt.3081 · Cited by 1,460
Self-citationTissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors
Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Girard, O. M., Hanahan, D., Mattrey, R. F., & Ruoslahti, E. I. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.10.013 · Cited by 1,140
Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing
Tsai, S. Q., Wyvekens, N., Khayter, C., Foden, J. A., Thapar, V., Reyon, D., Goodwin, M. J., Aryee, M. J., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2908 · Cited by 952
CRISPR-mediated direct mutation of cancer genes in the mouse liver
Xue, W., Chen, S., Yin, H., Tammela, T., Papagiannakopoulos, T., Joshi, N. S., Cai, W., Yang, G., Bronson, R., Crowley, D. G., et al. (2014) · Nature · doi:10.1038/nature13589 · Cited by 776
Flagged first, then by citations
Research works printed but not linked: 2
- 10.1126/science.1225829 · DOI · Paper page
- 10.1038/nmeth.3047 · DOI · Paper page
Cited by
Sorted by citations
Items 201–297 of 297
Zhuo, X., Wu, Y., Fu, X., Li, J., Xiang, Y., Liang, X., Mao, C., & Jiang, Y. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.08.013 · Cited by 12
Smart Bioinks as de novo Building Blocks to Bioengineer Living Tissues
Blaeser, A., Heilshorn, S. C., & Campos, D. F. D. (2019) · Gels · doi:10.3390/gels5020029 · Cited by 12
Nanomaterials in gene therapy and genome editing: challenges and emerging directions
Jiang, M., Zhang, K., Wang, Z., Gao, M., Su, S., He, J., Xu, H., Bo, Z., Jiang, Z., Zhang, C., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03895-w · Cited by 14
Nano-polymeric platinum activates PAR2 gene editing to suppress tumor metastasis
Jiang, Y., Li, Y., Zheng, D., Du, X., Yang, H., Wang, C., Zhao, M., Xiao, H., Zhang, L., Li, X., et al. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123090 · Cited by 11
Essential cues of engineered polymeric materials regulating gene transfer pathways
Islam, M. A., Park, T., Firdous, J., Li, H.-S., Jiménez-Pérez, Z. E., Lim, M., Choi, J.-W., Yun, C., & Cho, C. (2022) · Progress in Materials Science · doi:10.1016/j.pmatsci.2022.100961 · Cited by 12
Multi-functional engineered polypeptide-based drug delivery systems for improved cancer therapy
Li, X., Liu, J., Chen, H., Chen, Y., Wang, Y., Zhang, C. Y., & Xing, X. (2022) · Green Chemical Engineering · doi:10.1016/j.gce.2022.07.010 · Cited by 11
Self-citationCurrent landscape of treating different cancers using nanomedicines: Trends and perspectives
Salvador-Morales, C., & Grodzinski, P. A. (2023) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1927 · Cited by 10
Fatima, H., Singh, D., Muhammad, H., Acharya, S., & Aziz, M. A. (2024) · 3 Biotech · doi:10.1007/s13205-024-04186-1 · Cited by 12
Nanotherapeutic strategies exploiting biological traits of cancer stem cells
Wang, H., Zhang, W., Sun, Y., Xu, X., Chen, X., Zhao, K., Yang, Z., & Liu, H. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.03.016 · Cited by 11
Developing bioinspired delivery systems for enhanced tumor penetration of macromolecular drugs
Yang, J. P., Zeng, Z., Liu, Y., Li, Y., & Xu, X. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113845 · Cited by 9
Juan, A. M. T. S., Rodgers, T. M., Bedolla, C. N., Noriega, F., & Romero, G. (2020) · Journal of Applied Polymer Science · doi:10.1002/app.49377 · Cited by 9
Lipid‐, Inorganic‐, Polymer‐, and DNA‐Based Nanocarriers for Delivery of the CRISPR/Cas9 system
Song, N., Chu, Y., Tang, J., & Yang, D. (2023) · ChemBioChem · doi:10.1002/cbic.202300180 · Cited by 9
A Big Prospect for Hydrogel Nano-System in Glioma
Zhang, L., Teng, F., Xin, H., Xu, W., Wu, W., Yao, C., & Wang, Z. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s470315 · Cited by 9
Jiang, P., Gao, Y., Chen, X., Ke, Q., Jin, X., & Huang, C. (2018) · ACS Macro Letters · doi:10.1021/acsmacrolett.8b00545 · Cited by 9
Rodgers, T. M., Muzzio, N., Watson, C. D., & Romero, G. (2021) · Bioengineering · doi:10.3390/bioengineering8020016 · Cited by 9
Zheng, Q., Wang, W., Zhou, Y., Mo, J., Chang, X., Zha, Z., & Zha, L. (2023) · Biomaterials Science · doi:10.1039/d3bm00788j · Cited by 10
Intelligent DNA-Based Hydrogels for Bioanalysis and Therapeutics
Zhu, Q., Shen, C., Chen, R., Mao, C., He, Y., & Yang, K. (2023) · ACS Applied Polymer Materials · doi:10.1021/acsapm.3c01131 · Cited by 9
A novel method for the development of plasmid DNA-loaded nanoliposomes for cancer gene therapy
Baradaran, B., Mohammadi, A., Shamekhi, S., Majidazar, N., Dilmaghani, A., Soofiyani, S. R., McMillan, N. A. J., Lotfipour, F., & Hallaj‐Nezhadi, S. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01034-0 · Cited by 8
Ikram, M. D., & Rasheed, S. (2022) · Current Molecular Pharmacology · doi:10.2174/1874467215666220819143105 · Cited by 8
CRISPR-Cas9 based non-viral approaches in nanoparticle elicited therapeutic delivery
Rani, V., & Prabhu, A. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103737 · Cited by 8
Feng, J., Liu, Y., Pan, X., Jin, F., Wu, L., Chen, J., Wan, B., Zhang, X., Rodrigues, L. R., & Zhang, Y. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c08684 · Cited by 8
Functionalized chitosan as nano-delivery platform for CRISPR-Cas9 in cancer treatment
Nawaz, A., Ariffin, N. S., & Wong, T. W. (2025) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2025.101041 · Cited by 7
CRISPR-Cas technologies: Emerging tools from research to clinical application
Hyeon, H., Hwang, S., Luo, Y., Shin, E., Yeom, J., Kim, H., Ryu, M., & Lee, K. (2025) · The Journal of Microbiology · doi:10.71150/jm.2504012 · Cited by 7
Kordkatouli, M., Janlou, M. A. M., Sateei, A., Mousavi, M. M. H., & Dulskas, A. (2024) · Zahedan Journal of Research in Medical Sciences · doi:10.5812/zjrms-158109 · Cited by 7
Nanoparticle-based CRISPR/Cas Delivery: An Emerging Tactic for Cancer Therapy
Dilnawaz, F., & Acharya, S. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666221006112615 · Cited by 7
Clinical gene therapy development for the central nervous system: Candidates and challenges for AAVs
Leong, T. W., Pal, A., Cai, Q., Gao, Z., Li, X., Bleris, L. G., Hayenga, H. N., & Qin, Z. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.04.009 · Cited by 7
Delivery and adjuvant: liposomes for SARS-CoV-2 vaccines
Negari, I. P., Khoerunnisa, A. N., Tarwadi, Sari, A. N., & Chuang, T. (2025) · Biotechnologia · doi:10.5114/bta/207680 · Cited by 6
Transforming Cancer Diagnosis and Therapy Through Fluorescent Hydrogels: A Review
Masaeli, E., Srinivasan, S., & Rajabzadeh, A. R. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202502577 · Cited by 6
Zhang, C., Zhang, N., Yang, R., Qi, X., Huang, J., Liu, J., Li, S., Lovell, J. F., Ren, H., & Zhang, Y. (2025) · BMEMat · doi:10.1002/bmm2.70032 · Cited by 6
Self-citationSynergistic integration of hydrogels and cold plasma for biomedical applications and therapeutics
Kuddushi, M., Dal, P., Gan, H., Lu, D., & Zhu, D. Z. (2025) · Materials Horizons · doi:10.1039/d5mh01968k · Cited by 6
Vázquez-Domínguez, I., Öktem, M., Winkelaar, F. A., Nguyen, T. H., Hoogendoorn, A. D. M., Roschi, E., Astuti, G., Timmermans, R., Suárez-Herrera, N., Bruno, I., et al. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102345 · Cited by 7
Lee, S.-H., Lee, S., Lee, H., Kim, S., & Kim, D. (2024) · Small Science · doi:10.1002/smsc.202400447 · Cited by 6
Get ready for the CRISPR/Cas system: A beginner's guide to the engineering and design of guide RNAs
Ma, S., Lv, J., Feng, Z., Rong, Z., & Lin, Y. (2021) · The Journal of Gene Medicine · doi:10.1002/jgm.3377 · Cited by 8
Dhumal, V., Nair, R., Manoharan, B., Paul, P., Aalhate, M., Dhuri, A., Kanp, T., Rode, K., Mahajan, S., & Singh, P. K. (2025) · ACS Applied Bio Materials · doi:10.1021/acsabm.5c00793 · Cited by 5
Multifunctional Liposomes: Smart Nanomaterials for Enhanced Photodynamic Therapy
Yu, J., Kim, D., & Cha, G. D. (2025) · Biomimetics · doi:10.3390/biomimetics10100689 · Cited by 5
Nanocarrier-mediated CRISPR-Cas delivery: a novel approach against antibiotic-resistant superbugs
Almufarriji, F. M. (2026) · Saudi Pharmaceutical Journal · doi:10.1007/s44446-026-00064-4 · Cited by 5
Hydrogel-based mitochondrial therapies: A new frontier in disease treatment
Tang, Z., Jiang, Y., Ling, H., Shen, Y., Wu, X., Chu, C. H., Zhao, I. S., & Gan, X. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124071 · Cited by 5
Liu, S., Deng, S., Li, M., Chen, J., Yuan, Y., Zhao, H., Zhou, J., Wang, J., Zhang, H., & Cheng, D. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c16588 · Cited by 5
Self-citationPrecision Genome Editing: The Synergy of CRISPR and Nanotechnology in Cancer Treatment
Vikal, A., Maurya, R., Bhowmik, S., Patel, P., Singh, R., Gupta, G. D., & Kurmi, B. D. (2024) · Current Cancer Therapy Reviews · doi:10.2174/0115733947290474240315062214 · Cited by 5
Giri, A., Hong, I., Kwon, T. K., Kang, J., Jeong, J., Kweon, S., & Yook, S. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.144324 · Cited by 5
Research on the application of biomaterial-based responsive hydrogels in the tumor microenvironment
Yue, W., Zhu, X., Wu, Z., Qiang, W., Yang, Y., Zhang, Z., Wang, Y., Teng, Y., & Zhou, M. (2025) · PeerJ · doi:10.7717/peerj.19609 · Cited by 5
Advances in Magnetic Nanoparticle-Driven Delivery of Gene Therapies towards Prostate Cancer
Panday, R., Abdalla, A. M. E., Neupane, M., Khadka, S., Kricha, A., & Yang, G. (2021) · Journal of Nanomaterials · doi:10.1155/2021/6050795 · Cited by 5
Nanoscale delivery of phytochemicals targeting CRISPR/Cas9 for cancer therapy
Hussain, Y., Khan, H. Z., Ahmad, I. I., Efferth, T., & Alam, W. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153830 · Cited by 5
Intravaginal delivery for CRISPR–Cas9 technology: For example, the treatment of HPV infection
Zhen, S., Chen, H., Lu, J., Yang, X., Tuo, X., Chang, S., Tian, Y., & Li, X. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28552 · Cited by 5
Advances in Functionalized Biocomposites of Living Cells Combined with Metal–Organic Frameworks
Zhou, W., Long, Z., Xu, C., Zhang, J., Zhou, X. G., Song, X., Huo, P., Guo, Y. F., Xue, W., Wang, Q., et al. (2024) · Langmuir · doi:10.1021/acs.langmuir.4c00404 · Cited by 4
Fighting cancer smarter: Using hydrogel delivery systems to target chemokines
Khorramdelazad, H., Yaraghi, P., Shirzad, Z., Boroumand, A., Arfaei, R., Kheyri, A., Keshavarz, M., Daj, F., & Keykhaee, M. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118601 · Cited by 5
Hijacking migration: CXCL12-functionalized hydrogels as a new frontier in glioblastoma therapy
Khorramdelazad, H., Pourtorabi, S. M., Ghaffarinasab, M., & Sedghi, Z. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118921 · Cited by 4
Prime Editing, CRISPR-Cas9, and NanoCas Genome Editing for Cancer Treatment
Hossain, H., Sayeed, S. S. B., Islam, M. S., Ahmad, T., Brishty, K. A., Chowdhury, S. R., Alam, M. S., Mahmud, M. S., & Rahman, M. M. (2026) · Molecular Biotechnology · doi:10.1007/s12033-025-01548-9 · Cited by 5
Hydrogels in head and neck cancer: Innovations and translational advances in research and therapy
Wu, Z., Wu, Y., Alam, J., Viet, C. T., Dharmaraj, N., Molina, A. H., Sunga, G. M., Young, S., Amit, M., Li, X., et al. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124049 · Cited by 4
Enhenced cell adhesion on collagen I treated parylene-C microplates
Zhao, L., Lan, W., Dong, X., Han, X., Wang, L., Wei, Y., Hou, J., Huang, D., & Chen, W. (2021) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2021.1958465 · Cited by 4
CRISPR-Cas9 gene editing technology in human gene therapy: the new realm of medicine
Manasa, M. S. (2022) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20220796 · Cited by 4
Nano-bioink solutions for cardiac tissue bioprinting
Tomov, M. L., Vargas, M., Gil, C. J., Theus, A. S., Cetnar, A. C., Do, K. P., Veneziano, R., & Serpooshan, V. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817434-0.00012-x · Cited by 4
Inorganic Nanoparticles-based Drug Delivery Systems for Neurodegenerative Diseases Therapy
Bagherpour, I., Mozafari, M. R., & Naghib, S. M. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128352935250116064725 · Cited by 5
CRISPR/Cas9 gene editing in gastric cancer: Mechanisms, advances, and therapeutic potential
Christodoulidis, G., Bartzi, D., Tsagkidou, K., Dimaki, A., Lazaridou, L., Vakalou, K., Koumarelas, K. E., & Schizas, D. (2025) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v16.i3.107834 · Cited by 3
Cheng, X. I., Dong, J., Jain, P., Qin, S., Miao, Y., Liu, K., Theja, M. L. V., Butch, C. J., Wang, Y., & Lane, L. A. (2025) · Small · doi:10.1002/smll.202510436 · Cited by 4
Liposome-mediated anticancer drug delivery strategies for advancing brain tumor therapy
Rahmanian, M., Oroojalian, F., Kesharwani, P., & Sahebkar, A. (2025) · European Polymer Journal · doi:10.1016/j.eurpolymj.2025.114001 · Cited by 4
Polymer-Mediated Delivery of CRISPR-Cas9 Genome-Editing Therapeutics for CNS Disease
Iqbal, S., Alexander-Bryant, A. A., & Larsen, J. (2022) · Springer eBooks · doi:10.1007/978-3-031-11409-0_6 · Cited by 3
Injectable nanogel systems for brain drug delivery
Koyakutty, M., Devassy, G., Das, D. K., & Nair, S. V. (2023) · Precision Nanomedicine · doi:10.33218/001c.88217 · Cited by 3
Nanodelivery systems for gene editing drugs
Zhang, Y., & Ping, Y. (2025) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2025-0178 · Cited by 3
Nanosystems for gene therapy targeting brain damage caused by viral infections
da Silva, T. N., de Lima, E. V., Barradas, T. N., Testa, C. G., Picciani, P. H. S., Figueiredo, C. P., do Carmo, F. A., & Clarke, J. R. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100525 · Cited by 3
Novel Nanotechnology-Based Vector Delivery in CRISPR System for Transgene-Free Editing
Saeed, S., Ahmed, A., Nizamuddin, S., Qureshi, S. S., Shahzad, R., Khan, N. U., Shaban, M., Khan, M. H. U., & Khan, S. U. (2022) · Springer eBooks · doi:10.1007/978-3-030-96925-7_12 · Cited by 2
CRISPR/Cas9 Nano-delivery Approaches for Targeted Gene Therapy
Jacob, E. M., Borah, A., & Kumar, D. S. (2022) · Nanotechnology in the life sciences · doi:10.1007/978-3-031-12658-1_2 · Cited by 3
Zhang, P., Zhao, L., Liu, H., Chen, H., Wu, Y., Wang, X., Liu, G., & Zeng, Y. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202300228 · Cited by 2
Self-citationThe changing landscape of gene editing tool delivery in neurological disorders
Chen, Y., Paul, A., Collins, M. G., & Lee, H. Y. (2023) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2023.100509 · Cited by 2
Self-citationWestarp, P., Keller, T., Brand, J. S., Horvat, S., Albrecht, K., Beisel, C. L., & Gröll, J. (2025) · Discover Nano · doi:10.1186/s11671-025-04316-5 · Cited by 2
Fighting Cancer Using Nanoparticles – Diagnosis, Treatment and Monitoring
Cifrić, S., Spahić, L., Osmanović, D., Imamović, E., & Deumić, A. (2021) · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · doi:10.1007/978-3-030-73909-6_76 · Cited by 2
Recent advances in polymeric nanomedicines for glioblastoma therapy
Sun, Y., YiBin, W. A. N. G., YanJie, L. I. U., Zou, Y., Zheng, M., & Shi, B. (2020) · Scientia Sinica Vitae · doi:10.1360/ssv-2019-0212 · Cited by 3
Amalgamation of Nanoparticles within Drug Carriers: A Synergistic Approach or a Futile Attempt?
Mehta, N., & Pai, R. V. (2022) · Pharmaceutical Nanotechnology · doi:10.2174/2211738510666220902150449 · Cited by 2
Lipid-based nanomaterials as phototheranostic agents
Banerjee, J., Samanta, S., Dash, S. K., & Pramanik, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95758-8.00005-8 · Cited by 1
Lin, Q., Liu, M., Ke, L., Ong, N. W. X., Wong, J. H. M., Owh, C., Ow, V., Sim, B., Boo, Y. J., Lim, J. Y. C., et al. (2025) · BMEMat · doi:10.1002/bmm2.70020 · Cited by 1
Thakur, A., Sharma, R., Sharma, R., Jeet, K., & Deepak, A. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107705 · Cited by 1
DNA-Based Hydrogel: Programmable Architectures and Application Frontiers
Ishikawa, D. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1014046 · Cited by 1
Engineering Smart Hydrogels Through Dynamic Polymer Networks for Controlled Drug Delivery
Choi, C., Seo, D., Kim, T., Park, J., Yu, D., Yu, S., Shin, J., Yuk, S. A., Sung, D., & Kim, H. (2026) · Gels · doi:10.3390/gels12100884 · Cited by 1
ZBTB7B inhibits glioma tumorigenicity by upregulating GPR17 and CXCL10
Zhang, L., Zhang, H., Wang, C., Jiang, A., Zhao, F., Yang, S., Lei, H., Yu, X., Ren, J., Tang, C., et al. (2025) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjaf043 · Cited by 1
Self-citationNanocarriers for the delivery of the CRISPR/Cas9 system
Hwang, S., Ko, H., Lee, H.-Y., & Choi, J. H. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2598332 · Cited by 1
Liu, C., Li, Z., Zhang, Y., Ji, T., Sun, H., Wei, G., Zhang, L., & Xi, J. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.202503083 · Cited by 1
Nanoengineering Systems for Gene Therapy: Mechanisms, Modalities, and Future Directions
Mais, R., Kumar, A., Ahmetaj, A. A., Burgos-Crespo, G., Sanchez, M. M., Roxas, D., Dcosta, C., Ilyas, A., Hadjiargyrou, M., & Zanganeh, S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27135988 · Cited by 1
Cell and gene therapies—Emerging technologies and drug delivery systems for treating brain cancer
Ganipineni, L. P., Chan, Y., Ng, S. W., Kandalam, S., & Chereddy, K. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85503-7.00017-1 · Cited by 1
Emerging nanoparticles that target and eliminate cancer stem cells
Fan, Z., Chen, B., Yang, X., & Li, Z. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2544509 · Cited by 1
Liposome-Templated Hydrogel Nanoparticles for Targeted Delivery of CRISPR/Cas9 to Brain Tumors
Chen, Z., Chen, A. T., & Zhou, J. (2020) · Neuromethods · doi:10.1007/978-1-0716-1052-7_10 · Cited by 1
Self-citationDelivery Methods for CRISPR/Cas Reagents
Ashraf, S., Munawar, N., Zahoor, M. K., Jamil, A., Hammad, M., Ghaffar, A., & Ahmad, A. (2022) · Springer eBooks · doi:10.1007/978-981-16-6305-5_4 · Cited by 1
Targeted Therapeutics for Rare Disorders
Keeling, K. M., Leier, A., Bedwell, D. M., Chen, A. T., Kesterson, R. A., Marquez‐Lago, T. T., Müller, U. F., Zhou, J., Popplewell, L. J., & WALLIS, D. E. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824010-6.00009-5 · Cited by 1
Self-citationTurning Tables for CRISPR/Cas9 Editing System: From Scratch to Advanced Delivery Platforms
Chira, S., Nutu, A. M., Bica, C., Pop, L., Gherman, M., Angheluță, M.-D., & Berindan‐Neagoe, I. (2022) · Springer eBooks · doi:10.1007/978-3-030-80962-1_292-1 · Cited by 1
Brain-wide Genome Editing via STEP-RNPs for Treatment of Angelman SyndromePreprint
Lu, X., Xie, Y., Bao, Y., Yu, J., Wang, Z., Fan, J., Sheu, W. C., Long, G., Tu, Z., Tong, J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.13.684643 · Cited by 1
Self-citationProgress of nanoparticles inhibiting tumor metastasis
Gong, Z., Zhang, X., & Dai, Z. (2018) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/n972018-00016
Biomaterials for gene editing therapeutics
Shim, G., Kim, D., Le, Q., Byun, J., Park, J.-W., & Oh, Y. (2020) · Elsevier eBooks · doi:10.1016/b978-0-08-102983-1.00008-9
Tan, Z. (2019) · University of Minnesota Digital Conservancy (University of Minnesota)
[A man with progressive diplopia].
Crama, N., & Klevering, B. J. (2012) · PubMed
Kumari, S., Jena, D., Prajapati, V. K., Singh, S. R., & Tripathi, G. (2023) · Wiley eBooks · doi:10.1002/9781394175635.ch4
Brain-targeted delivery of CRISPR/Cas9 mediated glioblastoma therapeutics
Liu, S. (2023) · Theoretical and Natural Science · doi:10.54254/2753-8818/24/20231115
Nanomaterials in cancer treatment
Zhang, Z., Cao, X., Wang, C., Huang, Q., & Liu, Y. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95513-3.00023-x
Peptide-Assisted CRISPR/Cas9 Delivery to Tumors
Gustafsson, O., Andaloussi, S. E., & Nordin, J. Z. (2025) · Methods in pharmacology and toxicology · doi:10.1007/978-1-0716-4374-7_8
Turning Tables for CRISPR/Cas9 Editing System: From Scratch to Advanced Delivery Platforms
Chira, S., Nutu, A. M., Bica, C., Pop, L., Gherman, M., Angheluță, M.-D., & Berindan‐Neagoe, I. (2025) · Springer eBooks · doi:10.1007/978-3-032-00765-0_292
Ryu, Y. C., Bao, G., & Hwang, B. H. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118838
Additional file 1 of Multimodal targeting of glioma with functionalized nanoparticles
Marei, H. E. (2022) · Figshare · doi:10.6084/m9.figshare.20580878
Investigating the potential of CRISPR-Cas9 gene editing technology for gene therapy in cancer
Wani, S. N., Singh, S., Sharma, N., Behl, T., Zahoor, I., & Tantray, J. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-31592-3.00005-4
Mohiuddin, M., & Ahsan, M. A. M. (2026) · Health Science Reports · doi:10.1002/hsr2.73308
Metadata
- Authors
- Chen, Z., Liu, F., Chen, Y., Liu, J., Wang, X., Chen, A. T., Deng, G., Zhang, H., Liu, J., Hong, Z., & Zhou, J.
- Affiliations
- Nankai University (CN)
- Yale University (US)
- Corresponding author
- Hong, Zhangyong
- Zhou, Jiangbing
- ORCID
- Venue
- Advanced Functional Materials
- Publisher
- Wiley
- Published
- 2017-10-16
- Volume
- 27
- Issue
- 46
- ISSN
- 1616-301X (ISSN-L)
- 1616-3028
- PMC
- PMC5939593
- OpenAlex
- W2766680713
- Cited by
- 297
- References
- 41
- Citations by year
- 2026: 11 · 2025: 44 · 2024: 26 · 2023: 39 · 2022: 60 · 2021: 37 · 2020: 39 · 2019: 24 · 2018: 16
- FWCI
- 8.83
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Advanced Functional Materials (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (NS095817, NS095147)
- American Brain Tumor Association
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Keywords
- CRISPR/Cas9, cancer gene therapy, core-shell nanoparticles, nucleic acid delivery, DNA minicircles, single guide RNA, targeted tumor delivery, brain tumors, PLK1, tumor growth inhibition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
